Information  X 
Enter a valid email address

Metminco Limited (MNC)

  Print   

Tuesday 09 October, 2018

Metminco Limited

Change in Substantial Shareholding

RNS Number : 3879D
Metminco Limited
09 October 2018
 

 

CHANGE IN HOLDING BY A Significant Shareholder

Pursuant to Rule 17 of the AIM Rules for Companies, Metminco Limited ("Metminco" or the "Company") (ASX: MNC; AIM: MNC) advises that it has today received notification from Lanstead Capital L.P. (Lanstead) of a change in its interest in the ordinary share capital of Metminco. 

 

Lanstead, who holds 71,768,608 ordinary shares in Metmico, advises that its voting power has reduced from 8.51% to 6.85% as a result of dilution due to the recent allotment and issue of 135 million ordinary shares by the Company pursuant to the placement announced on 4 October 2018 (the Placement).  

 

·     The change in substantial shareholding interest took place on 3 October 2018;

·     Lanstead did participate in the Placement; and

·     Lanstead has not disposed of any ordinary shares, as such the number of ordinary shares held by Lanstead in the Company has not changed.

 

Andrew Metcalfe

 

Company Sectretary

 

For further information, please contact:

METMINCO LIMITED



Kevin Wilson, Executive Chairman


Mobile: +61 (0) 409 942 355

Geoff Widmer, Joint Company Secretary


Office:  +61 (0) 3 9819 3995

Andrew Metcalfe, Joint Company Secretary/CFO


Office:  +61 (0) 3 9867 7199

 

NOMINATED ADVISOR AND BROKER



RFC Ambrian



Australia



Andrew Thomson/Alena Broesder


Office:  +61 (0) 8 9480 2500

United Kingdom



Charlie Cryer


Office:  +44 (0) 20 3440 6800

 

PUBLIC RELATIONS



Camarco

United Kingdom



Gordon Poole / Nick Hennis


Office:  + 44 (0) 20 3757 4997

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
HOLUKSSRWAARRRA

a d v e r t i s e m e n t